AbbVie (ABBV) Other Non Operating Income (2012 - 2026)

AbbVie (ABBV) has 15 years of Other Non Operating Income data on file, last reported at -$2.3 billion in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$2.3 billion, down 59.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.2 billion (down 1172.05% YoY), and the FY2025 annual result was -$5.8 billion, down 27485.71% from the prior year.
• Other Non Operating Income improved to -$2.3 billion in Q1 2026 per ABBV's latest filing, from -$5.7 billion in the prior quarter.
• Over five years, Other Non Operating Income peaked at $3.1 billion in Q4 2024 and troughed at -$5.7 billion in Q4 2025.
• A 5-year average of -$1.0 billion and a median of -$586.0 million in 2024 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income surged 8722.22% in 2022, then slumped 2904.26% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $279.0 million in 2022, then sank by 1741.58% to -$4.6 billion in 2023, then jumped by 167.01% to $3.1 billion in 2024, then sank by 287.23% to -$5.7 billion in 2025, then jumped by 59.87% to -$2.3 billion in 2026.
• Business Quant data shows ABBV's Other Non Operating Income at -$2.3 billion in Q1 2026, -$5.7 billion in Q4 2025, and -$503.0 million in Q3 2025.